Reduction in Revascularization With Icosapent Ethyl: Insights From REDUCE-IT Revascularization Analyses

BACKGROUND: Patients with elevated triglycerides despite statin therapy have increased risk for ischemic events, including coronary revascularizations. METHODS: REDUCE-IT (The Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial), a multicenter, double-blind, placebo-controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterson, Benjamin E., Bhatt, Deepak L., Steg, Ph. Gabriel, Miller, Michael, Brinton, Eliot A., Jacobson, Terry A., Ketchum, Steven B., Juliano, Rebecca A., Jiao, Lixia, Doyle, Ralph T., Granowitz, Craig, Gibson, C. Michael, Pinto, Duane, Giugliano, Robert P., Budoff, Matthew J., Tardif, Jean-Claude, Verma, Subodh, Ballantyne, Christie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752247/
https://www.ncbi.nlm.nih.gov/pubmed/33148016
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.050276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752247/
https://www.ncbi.nlm.nih.gov/pubmed/33148016
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.050276

Ejemplares similares